AI Quick Read Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a ‘twin engine play’ to boost growth in the market as generic pricing pressure ...

Alembic Pharmaceuticals Ltd on Thursday said it has received tentative approval from the US health regulator for its generic version of Darolutamide tablets indicated for treatment of prostate cancer.

Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Fingolimod Capsules, 0.5 mg, the company announced on Saturday, April 25. The approval ...

New Delhi: Alembic Pharmaceuticals Limited has incorporated a wholly owned subsidiary, Alembic Pharmaceuticals GmbH, in Germany with an initial share capital of EUR 25,000, as part of its strategy to ...

New Delhi: Alembic Pharmaceuticals Limited has incorporated a new subsidiary, Alembic Lifesciences Philippines Inc., with a share capital of PHP 12 million, as part of its strategy to expand into the ...

Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its generic methotrexate injection, marking a significant addition to its oncology and ...

Vadodara: Alembic Pharmaceuticals is adding another regulated-market approval to its portfolio, reinforcing its presence in the US generics space with a key oncology and autoimmune therapy product.

Alembic Pharmaceuticals just got the green light from the US Food and Drug Administration for its generic methotrexate injection, available in two vial sizes. This medicine is used to treat certain ...

Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Methotrexate Injection USP, the company ...

Vadodara: Alembic Pharmaceuticals has strengthened its US generics portfolio with a key regulatory approval, positioning itself to tap into a high-value diabetes treatment market. Alembic ...